This study about selenoprotein P concentrations in individuals affected by neurodegenerative disease is apparently the first ever to have been carried out in vivo and using a biomarker within the central nervous system, in addition to the serum levels of this protein. Here, SELENOP is linked to neurodegenerative disease.